
Phathom Pharmaceuticals Inc (PHAT) with a beta value of 0.07 appears to be a promising investment opportunity.
On Monday, Phathom Pharmaceuticals Inc (NASDAQ: PHAT) was -9.12%% drop from the session before settling in for the closing price of $10.42. A 52-week range